KUALA LUMPUR (March 2): The Drug Control Authority has granted conditional approval for three more Covid-19 vaccines to be used in the country, according to Health director-general (D-G) Tan Sri Dr Noor Hisham Abdullah (pictured).
The three vaccines are AstraZeneca's Solution for Injection vaccine, Sinovac's CoronaVac Suspension for Injection vaccine and Pfizer's COMIRNATY Concentrate for Dispersion of Injection vaccine.
"This conditional registration requires the holding company to submit analysis of their latest data by rolling submission that will be evaluated by the National Pharmaceutical Regulatory Division (NPRA).
"This is to ensure that the effectiveness and safety of the vaccines are always updated and the 'benefits over risk' of the vaccines remain positive," said Dr Noor Hisham at a virtual press briefing today.
He added that NPRA is still evaluating two more Covid-19 vaccines, including the Russian-made Sputnik V.
Malaysia had previously approved the Pfizer-BioNTech vaccine to be used in the first phase of the National Covid-19 Immunisation Programme, which kicked off on Feb 26.
Prime Minister Tan Sri Muhyiddin Yassin and Dr Noor Hisham were among the first individuals to receive the vaccines, alongside frontliners.
Get the latest news @ www.EdgeProp.my
Subscribe to our Telegram channel for the latest stories and updates